EGFR and breast carcinoma: Our findings would seem to indicate that miR-326 is a regulator of cell proliferation, apoptosis, migration and invasion in breast cancer through targeting a gene network of ErbB/PI3K pathway (Figure 5), suggesting that miR-326 may serve as a promising target and diagnostic marker for treating breast cancer in the future.